Therapeutic Drug Monitoring of Mycophenolic Acid in Kidney Transplant Patients: A Abbreviated Sampling Strategy

Transplantation Proceedings

Volumn 39, Issue 3, 2007, Pages 596-599

  Muller, H ^a,b   Solari, S ^c   Zuniga, C ^b   Guerra, I ^c   Troncoso, J ^a   Ovalle, R ^a   Morente, J ^a   Pedreros, C ^a  

^a Hospital Las Higueras   (Chile)

^b UNIVERSIDAD CATÓLICA DE LA SANTÍSIMA CONCEPCIÓN   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; LINFONEX; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; ALGORITHM; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DRUG EXPOSURE; DRUG MONITORING; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MALE; PRIORITY JOURNAL; SAMPLING;

ADULT; ALGORITHMS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; REGRESSION ANALYSIS;

EID: 34147156189     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.12.027     Document Type: Article

References (14)

1. Allison A.C., and Eugui F.M. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 136 (1995) 5
2. Sollinger H.W., and US Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric allograft recipients. Transplantation 60 (1995) 225
3. Ojo A.O., Meier-Kriesche H.U., Hanson J.A., et al. Mycophenolate mofetil reduces late allograft loss independent of acute rejection. Transplantation 69 (2000) 2405
4. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded randomized clinical trial of mycophenolate mofetil for the prevention of cadaveric renal transplantation. Transplantation 61 (1996) 1029
5. Vanrenterghem Y., Lebranchu Y., Hene R., et al. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporin for prevention of acute renal allograft rejection. Transplantation 70 (2000) 1352
6. Houde I., Isenring P., Bouche D., et al. Mycophenolate mofetil, an alternative to cyclosporine A for long-term immunosuppression in kidney transplantation. Transplantation 70 (2000) 1251
7. Shaw C., Korecka M., and Brayman L. Pharmacokinetic-pharmacodynamic relationship for mycophenolic acid in renal transplant patients. Graft 2 (1994) 597
8. Bullingham R.E., Nicholls A.J., and Kamm B.R. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokin 34 (1998) 429
9. van Gelder T., Hilbrands L.B., Varenterghem Y., et al. A randomized double blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation 68 (1999) 261
10. Shaw L.M., Kaplan B., DeNofrio D., et al. Pharmacokinetic and concentration-control investigation of mycophenolic acid in adults after transplantation. Ther Drug Monit 22 (2000) 14
11. Yeung S., Tong K.L., Tsang W.K., et al. Determinatiuon of mycophenolate area under the curve by limited sampling strategy. Transplant Proc 33 (2001) 1052
12. Filler G., and Mai I. Limited sampling strategy for mycophenolic acid area under the curve. Ther Drug Monit 22 (2000) 169
13. Filler G., Feber J., Lepage N., et al. Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children. Pediatr Transplant 6 (2002) 411
14. Johnson A.G., Rigby R.J., Taylor P.J., et al. The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients. Clin Pharmacol Ther 66 (1999) 492